Re: Priceless on I.V. Regarding Zenith

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7656 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Priceless on I.V. Regarding Zenith

in response to

Re: Priceless on I.V. Regarding Zenith

Nextblockbuster

posted on Apr 09, 2017 01:08PM

Nbb - There could be a lot of truth in your words. Who will get the offer first, Zenith or Resverlogix? It's the ten billion dollar gorilla in the room.